Business Standard

Laurus Labs up 8% in two days on purchase orders from global pharma company

The company on Thursday said it has received purchase orders from a leading global life sciences company and the supplies will commence from March 2022.

Laurus Labs
Premium

Laurus Labs

SI Reporter Mumbai
Shares of Laurus Labs rallied 5 per cent intra-day to Rs 568 in an otherwise weak market on Friday, gaining 8 per cent in the past two trading days after the company on Thursday said it has received purchase orders from a leading global life sciences company and the supplies will commence from March 2022.

At 12:13 pm; the stock was trading 4 per cent higher at Rs 558.65, as compared to a 1.4 per cent decline in the S&P BSE Sensex.

“The company received purchase orders from a leading global life sciences company and the supplies will

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in